antique military cufflinks – Set includes officially licensed cufflinks and cushion money clip, Silver tone plated base metal with enamel, Money Clip features satin finish and sliding security grip closure, Officially licensed by DC Comics, Comes in a branded Batman gift box,
(Reuters) – A U.S antique military cufflinks. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing a patent related to a Baxalta hemophilia treatment, court records made public on Tuesday show. Jurors in the federal court in Wilmington, Delaware, reached their verdict on the seventh day of a trial after rejecting Baxalta’s argument that the June 2016 patent on the treatment, Adynovate, was invalid. Bayer said the infringement arose from Baxalta’s exclusive license agreement with Nektar Therapeutics, a San Francisco-based company that had done research with Bayer and knew about the patent, including through litigation in Germany..
The award covered the period from June 14, 2016, to Nov. 30, 2018 antique military cufflinks. Jurors applied a royalty rate of 17.78 percent to a royalty base of $872.84 million to arrive at the damages award. Bayer is based in Leverkusen, Germany, with U.S. offices in Whippany, New Jersey. Baxalta was based in Illinois before Shire Plc acquired the company in 2016. Takeda completed an acquisition of Shire for roughly $59 billion last month. Takeda said it was disappointed with the verdict and will consider its legal options..
“As a company, we are committed to developing and commercializing products with the best interest of patients in mind, and without violating the intellectual property rights of third parties,” it added. Bayer said it was pleased with the verdict, “which confirms the strength of Bayer’s innovation in hemophilia treatment.”. Hemophilia is a mostly inherited disorder where blood fails to clot properly. It can result in prolonged bleeding after an injury antique military cufflinks. Shire’s sales of Adynovate and other hemophilia treatments totaled $2.23 billion in the nine months ending Sept. 30, 2018, including $1.15 billion in the United States..
NEW YORK/WASHINGTON (Reuters) – U.S antique military cufflinks. drugmaker Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans to testify at a Senate hearing later this month examining rising prescription drug prices. Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee, on Monday invited executives from seven pharmaceutical companies, including Merck, to testify. The others are AbbVie Inc, AstraZeneca Plc , Bristol-Myers Squibb Co, Johnson & Johnson, Pfizer Inc and Sanofi SA..
A spokesman from Senator Grassley’s office said on Monday that two of the CEOs have agreed to testify so far, but did not specify from which companies. A Sanofi spokeswoman said the French drugmaker was reviewing Chief Executive Olivier Brandicourt’s scheduling to determine if he can attend the hearing. Britain-based AstraZeneca said it was reviewing the request and will respond to the committee antique military cufflinks. Pfizer, Bristol-Myers, and J&J did not immediately have a statement on the invitation to testify, while AbbVie did not respond to a request for comment..